Literature DB >> 7487236

Calcium antagonists should continue to be used for first-line treatment of hypertension.

M Epstein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7487236

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  5 in total

1.  Calcium channel blocker debate: true lies?

Authors:  J Leor; A Battler
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

Review 2.  Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature.

Authors:  David Cherney; Sharon Straus
Journal:  J Gen Intern Med       Date:  2002-12       Impact factor: 5.128

Review 3.  Manidipine: a review of its use in hypertension.

Authors:  S M Cheer; K McClellan
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Role of a third generation calcium antagonist in the management of hypertension.

Authors:  M Epstein
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 5.  Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.